Search Results - "De Lorenzo, Saverio"
-
1
Ertapenem in the treatment of multidrug-resistant tuberculosis: first clinical experience
Published in The European respiratory journal (01-01-2016)“…Treatment of multidrug-resistant (MDR) tuberculosis (TB) (defined as resistance to at least isoniazid and rifampicin, two core first-line drugs for TB…”
Get full text
Journal Article -
2
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis
Published in The European respiratory journal (01-12-2012)“…Linezolid is used off-label to treat multidrug-resistant tuberculosis (MDR-TB) in absence of systematic evidence. We performed a systematic review and…”
Get full text
Journal Article -
3
Towards tailored regimens in the treatment of drug-resistant tuberculosis: a retrospective study in two Italian reference Centres
Published in BMC infectious diseases (28-06-2019)“…The increased incidence of drug-resistant TB is a major challenge for effective TB control. Limited therapeutic options and poor treatment outcomes of DR-TB…”
Get full text
Journal Article -
4
Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy
Published in Journal of market access & health policy (2017)“…Objective: To evaluate the cost-effectiveness of bedaquiline plus background drug regimens (BR) for multidrug-resistant tuberculosis (MDR-TB) and extensively…”
Get full text
Journal Article -
5
The Italian registry of pulmonary non-tuberculous mycobacteria - IRENE: the study protocol
Published in Multidisciplinary respiratory medicine (09-08-2018)“…A substantial increase in pulmonary and extra-pulmonary diseases due to non-tuberculous mycobacteria (NTM) has been documented worldwide, especially among…”
Get full text
Journal Article -
6
Consensus Not Yet Reached on Key Drugs for Extensively Drug-Resistant Tuberculosis Treatment
Published in Clinical infectious diseases (15-07-2009)Get full text
Journal Article -
7
Bedaquiline in MDR/XDR-TB cases: first experience on compassionate use
Published in The European respiratory journal (01-01-2014)Get full text
Journal Article -
8
Efficacy and safety of meropenem-clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB
Published in The European respiratory journal (01-06-2013)“…Clinical experience on meropenem-clavulanate to treat tuberculosis (TB) is anecdotal (according to case reports on 10 patients). The aim of our case-control…”
Get full text
Journal Article -
9
Tuberculosis elimination, patients' lives and rational use of new drugs: revisited
Published in The European respiratory journal (01-02-2016)Get full text
Journal Article -
10
Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB
Published in The European respiratory journal (01-04-2016)“…No large study has ever evaluated the efficacy, safety and tolerability of meropenem/clavulanate to treat multidrug- and extensively drug-resistant…”
Get full text
Journal Article -
11
Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB
Published in The European respiratory journal (01-06-2016)“…No large study to date has ever evaluated the effectiveness, safety and tolerability of imipenem/clavulanate versus meropenem/clavulanate to treat multidrug-…”
Get full text
Journal Article -
12
Linezolid tolerability in multidrug-resistant tuberculosis: a retrospective study
Published in The European respiratory journal (01-10-2015)“…Linezolid is used off-label to treat multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) [1, 2]. Recently, two systematic reviews…”
Get full text
Journal Article -
13
Tuberculosis a re-emerging disease
Published in Internal and emergency medicine (01-10-2012)“…Two billion people, nearly one-third of the population worldwide, are infected by M. tuberculosis . Since 2008, the number of foreign TB cases in Italy has…”
Get full text
Journal Article -
14
Relationship between lymphocyte subsets values and C‐reactive protein in COVID‐19 patients
Published in Cytometry. Part A (01-05-2021)“…We enrolled 33 patients with COVID‐19 (23 men and 10 women; age 59 ± 15; males, n = 23; females, n = 10) admitted to the Department of Infectious Diseases of…”
Get full text
Journal Article -
15
-
16
Is there still room for therapeutic drug monitoring of linezolid in patients with tuberculosis?
Published in The European respiratory journal (01-04-2016)Get full text
Journal Article -
17
Extensively drug-resistant tuberculosis, Italy and Germany
Published in Emerging infectious diseases (01-05-2007)Get full text
Journal Article -
18
Availability of anti-tuberculosis drugs in Europe
Published in The European respiratory journal (01-08-2012)Get full text
Journal Article -
19
The Italian registry of pulmonary nontuberculous mycobacteria - IRENE: the study protocol
Published in Multidisciplinary respiratory medicine (11-12-2019)“…Background: A substantial increase in pulmonary and extra-pulmonary diseases due to non-tuberculous mycobacteria (NTM) has been documented worldwide,…”
Get full text
Journal Article -
20
Availability of anti-tuberculosis drugs in Europe: Table 1
Published in The European respiratory journal (01-08-2012)Get full text
Journal Article